Project Grant R01CA277778
Award Date 1/19/23
Completion Date 12/31/27
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Washington University a Project Grant totaling $425,088 on May 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a five-year research initiative examining lung cancer care and prognosis outcomes across Medicare delivery systems. The research will create nationally representative cohorts of lung cancer patients and individuals eligible for lung cancer screening to...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a $696,498 Project Grant to The MGH Institute of Health Professions, Inc. on May 1, 2026 (completion date: April 30, 2031) under the Cancer Cause and Prevention Research program (CFDA 93.393). This research project develops and optimizes a multicomponent intervention designed to improve functional recovery and increase participation in vocational, social, physical, and instrumental activities among breast cancer...
- This federal Project Grant award of $156,500, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a study titled "Nurses Surviving Breast Cancer: An Exploration of Breast Cancer Diagnosis, Reported Lymphedema Symptoms, and Lifestyle Status in the Nurses' Health Study Survey". The study aims to 1) explore patterns of incidence of self-reported breast cancer-related lymphedema (BCRL) symptoms, and 2) examine...
- Federal Grant Award Summary The National Cancer Institute awarded $125,619 to the Stowers Institute for Medical Research under the Cancer Cause and Prevention Research program (CFDA 93.393) effective August 1, 2025, through July 31, 2030. This Project Grant supports research into centromere biology and chromosome segregation mechanisms that contribute to genomic instability—a hallmark of cancer development. The primary deliverables include experimental research characterizing how natural...
- Federal Project Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $673,096 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded August 18, 2025, with completion targeted for July 31, 2030. The award supports implementation and evaluation of the BRIDGE Model, a person-centered collaborative care intervention designed to improve cancer and mental health care delivery for...
- Federal Grant Award Summary The National Cancer Institute awarded The Washington University a Project Grant totaling $160,093 under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct research on risk-based prostate cancer screening perceptions and informational needs among screening-eligible men. The two-year project, active from May 1, 2026 through April 30, 2028, focuses on understanding how men perceive the harms and benefits of prostate-specific antigen (PSA) screening...
- The National Cancer Institute (NCI) awarded a $656,181 Project Grant to The Washington University, Office of Sponsored Research Services, under the Cancer Cause and Prevention Research program (CFDA 93.393) on June 19, 2026. The award supports the CHOOSE (Communication and Hospice Online with Optimal Support and Engagement) initiative, a multisite, rigorously designed intervention study that will develop and test evidence-based facilitator communication strategies to enhance online support...
- The National Cancer Institute awarded the Regents of the University of Minnesota a $386,612 Project Grant effective August 13, 2025, through July 31, 2027, under the Cancer Cause and Prevention Research program (CFDA 93.393). This R21 exploratory/developmental grant supports research investigating how social and structural determinants of health (SSDOH) contribute to accelerated biological aging and cancer risk disparities among middle-aged and older adults. The project leverages existing data...
- Federal Project Grant Award Summary The National Cancer Institute (NCI), through its Cancer Research Manpower program (CFDA 93.398), awarded The Washington University a Project Grant of $333,504 effective July 1, 2025, through July 31, 2027. This award funds research investigating the dynamics and function of peritoneal myeloid cells during colorectal cancer (CRC) peritoneal dissemination and the implications for immunotherapy. The research aims to elucidate the unique roles of myeloid...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...